Duane Schulthess of Vital Transformation sits down at the DIA Global conference in Boston, for a one on one discussion with Jeff Allen, CEO of Friends of Cancer Research from Washington DC.
Washington DC’s Friends of Cancer Research is an advocacy group that has had a profound influence on how we bring new cancer therapies to market. Friends played a key role establishing the FDA’s breakthrough designation, and their president and CEO, Jeff Allen, is now focused on harnessing Real World Evidence to improve the way we evaluate oncology treatment. Register for their RWE Conference on July 10th, here.
To listen to the podcast, click below.